Faculty of Arts and Design, Center for General Education, Durban University of Technology, Durban, South Africa.
Health Economics and HIV/AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa.
Front Public Health. 2022 Jun 17;10:691729. doi: 10.3389/fpubh.2022.691729. eCollection 2022.
The national policy on oral pre-exposure prophylaxis (PrEP) for female sex workers (FSWs) was instituted in South Africa in 2016. FSWs were targeted for PrEP due to a Human immunodeficiency virus (HIV) prevalence of 57.7%, which is higher than the prevalence of 19.07% among the general population. Research from demonstration studies has shown that uptake of PrEP has been slower than anticipated, and the purpose of this study was to explore barriers to the uptake of PrEP among FSWs.
An in-depth qualitative study was conducted with 39 participants, 30 individual participants, and nine focus group participants. Eleven participants consisted of peer educators and two health workers from a sex work and PrEP distribution organization, the rest of the participants (1) were FSWs.
The majority of participants mentioned that little distinction was made between PrEP and antiretrovirals (ARVs) taken by FSWs living with HIV. PrEP was not distributed through public health care facilities, and health workers unknowingly labeled PrEP as ARVs. Consequently, health workers seen as experts created suspicion and contributed to the mistrust of PrEP among FSWs due to mixed messages, and equating PrEP to ARVs reduced uptake. Furthermore, failure to make a clear distinction between oral PrEP and ARVs resulted in accusations of lying, denialism, and deception leveled at users of PrEP by FSWs using ARVs, and sometimes by clients and intimate partners. FSWs using PrEP reported feeling stigmatized and thrust into interpersonal conflict with their peers after choosing PrEP, leading to broken relationships, and some resorting to taking PrEP privately or discontinuing PrEP altogether.
Pre-exposure prophylaxis as an ARV targeted for the prevention of HIV among high-risk groups was found to be stigmatizing. The distinctive use of PrEP and ARVs should be correctly explained to users to minimize confusion, enable differentiation and reduce interpersonal conflict. Cohesion among sex work organizations and public health care facilities is needed to disseminate the correct knowledge on PrEP. A non-stigmatizing approach to the distribution of PrEP may serve to increase uptake and adherence.
南非于 2016 年出台了针对女性性工作者(FSW)的口服暴露前预防(PrEP)国家政策。由于 HIV 感染率为 57.7%,FSW 成为 PrEP 的目标人群,高于普通人群 19.07%的感染率。来自示范研究的研究表明,PrEP 的采用速度低于预期,本研究的目的是探讨 FSW 采用 PrEP 的障碍。
对 39 名参与者进行了深入的定性研究,其中 30 名是个人参与者,9 名是焦点小组参与者。11 名参与者是性工作和 PrEP 分发组织的同伴教育者和两名卫生工作者,其余参与者(1)是 FSW。
大多数参与者提到,PrEP 和接受 HIV 治疗的 FSW 服用的抗逆转录病毒药物(ARV)之间几乎没有区别。PrEP 并未通过公共卫生保健机构分发,卫生工作者无意中将 PrEP 标记为 ARV。因此,由于信息混杂,被视为专家的卫生工作者引起了怀疑,并导致 FSW 对 PrEP 的不信任,将 PrEP 等同于 ARV 会降低采用率。此外,未能明确区分口服 PrEP 和 ARV 导致 FSW 对使用 ARV 的 PrEP 用户进行指责,包括撒谎、否认和欺骗,有时甚至是客户和亲密伴侣。选择 PrEP 的 FSW 报告称,感到受到污名化,并在选择 PrEP 后与同行陷入人际冲突,导致关系破裂,一些人转而私下服用 PrEP 或完全停止服用 PrEP。
作为预防高危人群 HIV 的 ARV,暴露前预防被发现具有污名化。应向使用者正确解释 PrEP 和 ARV 的独特用途,以减少混淆、区分和减少人际冲突。需要性工作组织和公共卫生保健机构之间的凝聚力来传播关于 PrEP 的正确知识。采用非污名化的 PrEP 分发方法可能有助于提高采用率和依从性。